These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1378277)

  • 1. Beta 2-adrenergic receptor antibodies in myasthenia gravis.
    Eng H; Magnusson Y; Matell G; Lefvert AK; Saponja R; Hoebeke J
    J Autoimmun; 1992 Apr; 5(2):213-27. PubMed ID: 1378277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against beta1 and beta2 adrenergic receptors in myasthenia gravis.
    Xu BY; Pirskanen R; Lefvert AK
    J Neuroimmunol; 1998 Nov; 91(1-2):82-8. PubMed ID: 9846822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas' disease.
    Elies R; Ferrari I; Wallukat G; Lebesgue D; Chiale P; Elizari M; Rosenbaum M; Hoebeke J; Levin MJ
    J Immunol; 1996 Nov; 157(9):4203-11. PubMed ID: 8892658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.
    Tzartos SJ; Cung MT; Demange P; Loutrari H; Mamalaki A; Marraud M; Papadouli I; Sakarellos C; Tsikaris V
    Mol Neurobiol; 1991; 5(1):1-29. PubMed ID: 1725702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor.
    Shenoy M; Oshima M; Atassi MZ; Christadoss P
    Clin Immunol Immunopathol; 1993 Mar; 66(3):230-8. PubMed ID: 7679342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
    Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA
    J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunopathology of myasthenia gravis.
    Lennon VA
    Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis.
    Moiola L; Protti MP; Manfredi AA; Yuen MH; Howard JF; Conti-Tronconi BM
    Ann N Y Acad Sci; 1993 Jun; 681():198-218. PubMed ID: 7689306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The T-cell repertoire in myasthenia gravis involves multiple cholinergic receptor epitopes.
    Link H; Xu ZY; Melms A; Kalbacher H; Sun JB; Wang ZY; Fredrikson S; Olsson T
    Scand J Immunol; 1992 Sep; 36(3):405-14. PubMed ID: 1381518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-presynaptic membrane receptor antibodies in myasthenia gravis.
    Lu CZ; Link H; Mo XA; Xiao BG; Zhang YL; Qin Z
    J Neurol Sci; 1991 Mar; 102(1):39-45. PubMed ID: 1856731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell responses in EAMG-susceptible and non-susceptible mouse strains after immunization with overlapping peptides encompassing the extracellular part of Torpedo californica acetylcholine receptor alpha chain. Implication to role in myasthenia gravis of autoimmune T-cell responses against receptor degradation products.
    Oshima M; Yokoi T; Deitiker P; Atassi MZ
    Autoimmunity; 1998; 27(2):79-90. PubMed ID: 9583739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of human-Torpedo hybrid acetylcholine receptor (AChR) for analysing the subunit specificity of antibodies in sera from patients with myasthenia gravis (MG).
    Loutrari H; Kokla A; Trakas N; Tzartos SJ
    Clin Exp Immunol; 1997 Sep; 109(3):538-46. PubMed ID: 9328134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human IgG monoclonal autoantibodies against muscle acetylcholine receptor: direct evidence for clonal heterogeneity of the antiself humoral response in myasthenia gravis.
    Cardona A; Garchon HJ; Vernet-der-Garabedian B; Morel E; Gajdos P; Bach JF
    J Neuroimmunol; 1994 Aug; 53(1):9-16. PubMed ID: 8051300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How subtle differences in MHC class II affect the severity of experimental myasthenia gravis.
    Yang B; McIntosh KR; Drachman DB
    Clin Immunol Immunopathol; 1998 Jan; 86(1):45-58. PubMed ID: 9434796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CTLA-4 antibody treatment triggers determinant spreading and enhances murine myasthenia gravis.
    Wang HB; Shi FD; Li H; Chambers BJ; Link H; Ljunggren HG
    J Immunol; 2001 May; 166(10):6430-6. PubMed ID: 11342669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell activation in vitro by helper T cells specific to region alpha 146-162 of Torpedo californica nicotinic acetylcholine receptor.
    Rosenberg JS; Oshima M; Atassi MZ
    J Immunol; 1996 Oct; 157(7):3192-9. PubMed ID: 8816433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-receptor antibodies in human disease.
    Fraser CM; Venter JC
    J Allergy Clin Immunol; 1984 Nov; 74(5):661-73. PubMed ID: 6209320
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of myosin ATPase activity by human myasthenia gravis antibodies reactive with the acetylcholine receptor.
    Mohan S; Krolick KA
    FEBS Lett; 1993 Feb; 318(1):50-2. PubMed ID: 8436225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.